On January 27, Trevena Inc. (TRVN) declared the acceptance of NDA submission for oliceridine injection by China NMPA. Following the announcement, the stock became bullish
Travena, Inc. (TRVN) stock prices were down 3.24% shortly after market trading commenced on July 27th, 2021, bringing the price per share down to USD$1.3464.
In after-hours trading, shares of Trevena Inc. (TRVN) were down -12.76% on Friday. The stock closed the previous trading session up 2.62% or $0.05 at
The shares of Trevena Inc. (TRVN) were up 6.44% in premarket trading at $2.15. TRVN stock closed at $2.02 yesterday, down -8.18% or $0.18. TRVN
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.